In our latest Aligned blog, we spoke with Ramya Ramaswami, M.B.B.S., M.P.H., Lasker Clinical Research Scholar in the HIV and AIDS Malignancy Branch, about her career, immigrating to the U.S. and the role resilience has played in her success.

▶️ go.cancer.gov/OQlSXli

Wish I were @ASH to see Kate Lurain et al's important rb.gy/5f7c6d on CATCH-IT RWE for anti-PD1 in #HIV #Hodgkin #lymphoma today. Encouraging activity after med 2nd line Tx in EBV+ disease (unique biology in HIV ): 70% CR rate, 20 mo DOR including in low CD4!

The #NIHHemeOncFellowship sends our best wishes for the match to all aspiring hematology and oncology fellows! National Cancer Institute NIH NHLBI NIH Clinical Center NCI Center for Cancer Research #Match2023

Each year, the #NIHHemeOncFellowship hosts a Research Retreat for 1st-year fellows as one of many steps to mentor them in their professional development & research planning. At our most recent retreat, fellows & directors also enjoyed the beautiful day. @NIH_NHLBI NCI Center for Cancer Research

Congrats to my dear friend and amazing clinician-scientist Ramya Ramaswami We couldn’t be luckier to have her brilliant research and compassionate care for our patients in the HIV and AIDS Malignancy Branch NCI Center for Cancer Research

Congratulations to our inspirational #LEAD2023 Rising Star Jaydira Del Rivero, MD Women Leaders in Oncology

Tishiya Carey, former postbac fellow in the HIV and AIDS Malignancy Branch, presenting her work on survival outcomes in older people living with HIV and cancer. Ramya Ramaswami Kate Lurain #AACRdisp23

I'm excited to share that our new paper is published. Many thanks to our wonderful team that made this possible. We are also grateful to the clinical trial participants for their contributions. #kshv #hhv8 #RNAseq #herpes #virus #OpenAccess doi.org/10.1186/s12967…

Excited to see the important results of BV-AVD in HIV+ Hodgkin lymphoma in print!

2-yr PFS 87% and OS 92% plus increases CD4/CD8 counts. Great work by Paul Rubinstein and AMC Operations

sciencedirect.com/science/articl…

Also such a wonderful group of caring and compassionate clinical researchers! Congrats on your achievements Kate Lurain and Ramya Ramaswami 👏🏻

Over the past week, we’ve been getting to know our newest #NIHHemeOncFellows , including at a get-together at Director Jen Kanakry’s home with our chiefs, associate directors and coordinators, as well as significant others, on hand. #worklifebalance

Excited to share our publication showing that personalized behavioral interventions improve engagement in care for people living with HIV #hivonc Grateful for the opportunity to work with amazing colleagues Elvin Geng Maya Petersen Eliud Akama Harriet Fridah Kenya Medical Research Institute

Last in-person Friday didactics of the 2022-23 cycle, celebrating our ultra-dedicated chief Krithika Shanmugasundaram and her incoming🤰🏽👶 with a multi-national potluck 🇮🇳🇨🇲🇧🇷🇨🇦🇵🇰🇺🇸🇩🇪🇰🇷 🇮🇪 Hem-Onc Fellows Network life NCI CCR Med Onc Service

Incidence of Burkitt lymphoma in the United States during 2000 to 2019 - PubMed: BL rates are multimodal- biological heterogeneity?; rates rose and fell-diagnostic or etiological factors? Survival improved by 20% points, but still low in black individuals. pubmed.ncbi.nlm.nih.gov/37278097/

Very timely Oncology Grand Rounds Journal of Clinical Oncology on HIV/ICI. Here, Kate Lurain elegantly summarizes the literature w/ informative recommendations for clinical practice and presents a case of a person living with HIV + Hodgkin Lymphoma who had a complete response to Pembrolizumab.

Best part about conferences is catching up with, and seeing friends do great things. Jennifer Crombie, MD Kate Lurain #ASCO23

Particularly enjoyed this plenary session as people with HIV (PWH) were included and enrolled.

Important that this was done with increasing incidence of Hodgkin lymphoma in PWH #HIVOnc

Prior, current, and incoming #NIH_Heme_Onc_Fellows including the associate program director Kate Lurain finding some time to socialize in between their multiple #ASCO23 educational, scientific, and networking activities.

Very heartwarming to see that our research was very welcomed by the #MedTwitter community! Toni Choueiri, MD Guru P. Sonpavde, MD Kate Lurain Ramya Ramaswami Elad Sharon Nazli Dizman Brinda Emu Tarek Haykal, MD IMG Oncologists Dana-Farber Lank Center for Genitourinary Oncology Yale Internal Medicine #CATCHIT